Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 622.92 million compared to CNY 584.14 million a year ago. Net income was CNY 117.93 million compared to CNY 93.75 million a year ago.

Basic earnings per share from continuing operations was CNY 0.875 compared to CNY 0.696 a year ago. Diluted earnings per share from continuing operations was CNY 0.867 compared to CNY 0.696 a year ago.